Fundraising FoxPfizer Venture Investments — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
EvolveImmune Therapeuticsevolveimmune.cominDec 2023
EvolveImmune develops immunotherapy treatments for cancer patients.
BiotechHealthtechMedical DevicesBranford, US
Stephen Bloch(Co-founder and Chief Executive Officer)inDonmienne Leung(Manager)Ian Taylor(Manager)Jay Fine(President, Research and Development)
BoardDerek Yoon(Manager)inJasmina Marjanovic(Manager)in
Co-investorsSolasta VenturesPfizer VenturesElm Street VenturesTakeda Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.